CSIMarket Company Name, Ticker, Suppliers, else..


Immunovant Inc   (NASDAQ: IMVT)
Other Ticker:  
 

Immunovant Inc

IMVT's Fundamental analysis



Immunovant Inc 's sales fell in the third quarter of 2024 from the same quarter a year ago.

Biotechnology & Pharmaceuticals industry recorded deterioration of revenues by -2.05 %

Immunovant Inc net loss increased from $-51 millions, to $-111 millions in third quarter of 2024,

• More on IMVT's Growth


Immunovant Inc
realized a net loss in trailing twelve months.

Immunovant Inc realized cash reduction of $ -2.15 per share in trailing twelve-month period.
Biotechnology & Pharmaceuticals industry recorded net loss in trailing twelve months.
Company
-
PE TTM   
Industry
-
PE TTM    
Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 5.79.


• More on IMVT's Valuation
 
 Total Debt (Millions $) -
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ -
 Net Income/Employee (TTM) $ -
 Receivable Turnover (TTM) -
 Tangible Book Value (Per Share $) 2.40

Immunovant Inc
realized net loss in trailing twelve months.

Immunovant Inc realized cash outflow of $ -2.15per share in trailing twelve-month period.
Biotechnology & Pharmaceuticals industry recorded net loss in trailing twelve months.
Company
-
PE TTM   
Industry
-
PE TTM    
Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 5.79.

Immunovant Inc Price to Book Ratio is at 5.84 lower than Industry Avg. of 72794.86. and higher than S&P 500 Avg. of 0.01

• More on IMVT's Valuation

•  Market Capitalization (Millions $) 2,060
•  Shares Outstanding (Millions) 147
•  Employees 207
•  Revenues (TTM) (Millions $) -
•  Net Income (TTM) (Millions $) -383
•  Cash Flow (TTM) (Millions $) -316
•  Capital Exp. (TTM) (Millions $) -1
•  Total Debt (Millions $) -
•  Dividend TTM ($) 0 $
•  Dividend Yield TTM (%) -
•  Revenue/Employee (TTM) $ -
•  Net Income/Employee(TTM) $ -
•  Receivable Turnover Ratio (TTM) -
•  Tangible Book Value (Per Share $) 2.40

•  Market Capitalization (Millions $) 2,060
•  Shares Outstanding (Millions) 147
•  Employees 207
•  Revenues (TTM) (Millions $) -
•  Net Income (TTM) (Millions $) -383
•  Cash Flow (TTM) (Millions $) -316
•  Capital Exp. (TTM) (Millions $) -1





  Ratio
•   Capital Ratio (MRQ) 6.04
•  Total Debt to Equity (MRQ) -
•  Tangible Leverage Ratio (MRQ) 0.19
•  Asset Turnover Ratio (TTM) -
•  Inventory Turnover Ratio (TTM) -





Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com